View Cart (0 items)

Items Tagged with 'generic drugs'


US regulator to tighten scrutiny on potential drug delay deals

June 24, 2014
The U.S. Federal Trade Commission has announced plans to increase probes into pharmaceutical deals that potentially harm competition by delaying the launch of generic drugs on the market.
Read More

US, EU generic drug makers call for regulatory cooperation

April 16, 2014
Generic pharmaceuticals manufacturers from Europe and the United States have urged regulators on both sides of the Atlantic to adopt a strategy of "regulatory convergence."
Read More

FDA reviewer slams study that questions generic drug quality

March 28, 2014
A senior official with the U.S. FDA has slammed research that suggests many heart drugs produced outside the U.S. contain impurities.
Read More

Pfizer seeks to ban sales of generic Viagra in US

March 24, 2014
U.S. pharmaceutical corporation Pfizer has filed a lawsuit against Indian drug maker Torrent Pharmaceuticals Ltd. in an effort to prevent sales of a generic version of Viagra.
Read More

Canada's drug spending growth slowed by generics

March 19, 2014
Market share is increasing for generics drugs, which are typically much cheaper than branded and patented drugs.
Read More

Many generic drugs fail to serve their purpose, doctors warn

March 4, 2014
Doctors and researchers have criticized the U.S. Food and Drug Administration (FDA) for failing to control the effectiveness of the vast majority of pharmaceutical products sold in the United States.
Read More

US, European watchdogs join forces to regulate generic drugs

January 6, 2014
The European Medicines Agency and the U.S. Food and Drug Administration have started a joint program for sharing information on bioequivalence studies required during the process of approval for generic drugs.
Read More

FDA imposes new ban on Wockhardt drugs

December 4, 2013
Indian generic drug maker Wockhardt has been hit by a U.S. import alert for the second time this year.
Read More

Generics dent market share of brand-name drugs

October 4, 2013
The growth of the generic drug market worldwide may turn out to be a long-term trend, experts say, as a number of studies show a stable decline in prescriptions of brand-name drugs last year.
Read More

Generic drug patent settlements cut costs for health systems, study finds

July 11, 2013
The U.S. health system saved a total of $25.5 billion between 2005 and 2012 thanks to generic drugs being launched on the market before patent expirations as a result of patent settlements.
Read More